Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate [clinicaltrials:NCT00898404]

Bio2RDF uri

Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate [clinicaltrials:NCT00898404]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00898404

Bio2RDF identifier

NCT00898404

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00898404

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00898404

anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]

150

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00898404 arm group 08a4df479e15ec87e5cf6d58e58b6e85 [clinicaltrials_resource:NCT00898404/arm-group/08a4df479e15ec87e5cf6d58e58b6e85]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:ca1954f55de6b13c270f49787460e895

brief summary [clinicaltrials_vocabulary:brief-summary]

This laboratory study i ...... drug resistance in patients.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Response or Resistance to Chem ...... emia Treated With Methotrexate

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Molecular basis for human reduced folate carrier (hRFC) transcripts Up to 4 years [clinicaltrials_resource:544a7a6ccabde9e20e3ffc0bea16b95b]

Molecular basis for human reduced folate carrier (hRFC) transcripts Up to 4 years [clinicaltrials_resource:8a861850574e7ab536ea4ce9dd3789e6]

Molecular basis for human reduced folate carrier (hRFC) transcripts Up to 4 years [clinicaltrials_resource:e18ce1b2b9cfd40996d65631d62ace49]

Molecular basis for human reduced folate carrier (hRFC) transcripts Up to 4 years [clinicaltrials_resource:e1ac273cafc491f84762ea98cf65cb7c]

detailed description [clinicaltrials_vocabulary:detailed-description]

OBJECTIVES: I. D ...... he National Cancer Institute.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00898404 [clinicaltrials_resource:dabab6f66e8129847e135034b302a2a2]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2009-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

laboratory biomarker analysis [clinicaltrials_resource:5b31390aac23b9eac16b773d0b5e5031]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Children's Oncology Group [clinicaltrials_resource:8d4ce296d99970495e6b388fde616248]

location [clinicaltrials_vocabulary:location]

Children's Oncology Group [clinicaltrials_resource:d563fda01246671ed514ec1c933bbd01]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00898404

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Molecular Correlates of Methotrexate in Childhood ALL

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

AALL04B1

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Larry Matherly [clinicaltrials_resource:ad99b5a67c304dd005dd0ad1a3651ed7]

overall status [clinicaltrials_vocabulary:overall-status]

Recruiting [clinicaltrials_resource:5231dee7156b84b0d1854de1a18dd169]

oversight [clinicaltrials_vocabulary:oversight]

United States: Institutional Review Board [clinicaltrials_resource:b46c5f1ee626ee51e33e6c048a7b19f6]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2100-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

secondary id [clinicaltrials_vocabulary:secondary-id]

NCI-2009-00308

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Children's Oncology Group [clinicaltrials_resource:8d4ce296d99970495e6b388fde616248]

start date [clinicaltrials_vocabulary:start-date]

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00898404 study design [clinicaltrials_resource:71bc0be96b6eb5b2e86c0fc5e8b8d728]

study type [clinicaltrials_vocabulary:study-type]

Observational [clinicaltrials_resource:d91f8943e6c920253e1301b3d81445a1]

url [clinicaltrials_vocabulary:url]

NCT00898404

verification date [clinicaltrials_vocabulary:verification-date]

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00898404

http://www.w3.org/2001/XMLSchema#string

title

Response or Resistance to Chem ...... emia Treated With Methotrexate

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Response or Resistance to Chem ...... e [clinicaltrials:NCT00898404]

@en